The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
IMODIUM Multi-Symptom Relief
loperamide hydrochloride and dimethicone · LOPERAMIDE HYDROCHLORIDE 2 mg/1; DIMETHICONE 125 mg/1 · Tablet · Oral · Kenvue Brands LLC
NDC 50580-0338-06 · 1 BLISTER PACK in 1 CARTON / 6 TABLET in 1 BLISTER PACK · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA021140
- TE code
- —
- Approval date
- Nov 30, 2000
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of loperamide hydrochloride and dimethicone (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Kenvue Brands LLC | LOPERAMIDE HYDROCHLORIDE 2 mg/1; DIMETHICONE 125 mg/1 | Aug 20, 2026 | Aug 31, 2026 |
| Kenvue Brands LLC | LOPERAMIDE HYDROCHLORIDE 125 mg/1; DIMETHICONE 2 mg/1 | Jul 22, 2026 | Aug 20, 2026 |
| Kenvue Brands LLC | DIMETHICONE 125 mg/1; LOPERAMIDE HYDROCHLORIDE 2 mg/1 | Jul 15, 2026 | Jul 18, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "IMODIUM Multi-Symptom Relief — NDC 50580-0338-06," retrieved September 3, 2026, https://drugdashboards.com/drug/50580033806.
Free to cite with attribution — see how the data is put together.